Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Comprehensive molecular characterization of a heavy chain deposition disease case.

Bender S, Ayala MV, Javaugue V, Bonaud A, Cogné M, Touchard G, Jaccard A, Bridoux F, Sirac C.

Haematologica. 2018 Nov;103(11):e557-e560. doi: 10.3324/haematol.2018.196113. Epub 2018 Jul 19. No abstract available.

2.

Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.

Bridoux F, Javaugue V, Bender S, Leroy F, Aucouturier P, Debiais-Delpech C, Goujon JM, Quellard N, Bonaud A, Clavel M, Trouillas P, Di Meo F, Gombert JM, Fermand JP, Jaccard A, Cogné M, Touchard G, Sirac C.

Kidney Int. 2017 Feb;91(2):423-434. doi: 10.1016/j.kint.2016.09.004. Epub 2016 Oct 20.

PMID:
27773425
3.

Impaired Lysosomal Function Underlies Monoclonal Light Chain-Associated Renal Fanconi Syndrome.

Luciani A, Sirac C, Terryn S, Javaugue V, Prange JA, Bender S, Bonaud A, Cogné M, Aucouturier P, Ronco P, Bridoux F, Devuyst O.

J Am Soc Nephrol. 2016 Jul;27(7):2049-61. doi: 10.1681/ASN.2015050581. Epub 2015 Nov 27.

4.

Efficient AID targeting of switch regions is not sufficient for optimal class switch recombination.

Bonaud A, Lechouane F, Le Noir S, Monestier O, Cogné M, Sirac C.

Nat Commun. 2015 Jul 6;6:7613. doi: 10.1038/ncomms8613.

PMID:
26146363
5.

A mouse model recapitulating human monoclonal heavy chain deposition disease evidences the relevance of proteasome inhibitor therapy.

Bonaud A, Bender S, Touchard G, Lacombe C, Srour N, Delpy L, Oblet C, Druilhe A, Quellard N, Javaugue V, Cogné M, Bridoux F, Sirac C.

Blood. 2015 Aug 6;126(6):757-65. doi: 10.1182/blood-2015-03-630277. Epub 2015 Jun 25.

6.

B-cell receptor signal strength influences terminal differentiation.

Lechouane F, Bonaud A, Delpy L, Casola S, Oruc Z, Chemin G, Cogné M, Sirac C.

Eur J Immunol. 2013 Mar;43(3):619-28. doi: 10.1002/eji.201242912. Epub 2013 Jan 24.

Supplemental Content

Loading ...
Support Center